¼¼°èÀÇ ½Å°æ¿Ü°ú Á¦Ç° ½ÃÀå
Neurosurgical Products
»óǰÄÚµå : 1564972
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,387,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½Å°æ¿Ü°ú Á¦Ç° ¼¼°è ½ÃÀåÀº 2030³â±îÁö 221¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â 114¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½Å°æ¿Ü°ú Á¦Ç° ¼¼°è ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 10.0% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 221¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ »öÀü¼ú Á¦Ç°Àº CAGR 10.6%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 88¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æ ³»½Ã°æ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 10.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 32¾ï ´Þ·¯, Áß±¹Àº CAGR 9.3%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ½Å°æ¿Ü°ú Á¦Ç° ½ÃÀåÀº 2023³â 32¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 33¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 9.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 9.3%¿Í 8.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 7.9%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ½Å°æ¿Ü°ú Á¦Ç° ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

½Å°æ¿Ü°ú Á¦Ç°À̶õ ¹«¾ùÀ̸ç, ¿Ö Çö´ë ¼ö¼ú¿¡ ÇʼöÀûÀΰ¡?

½Å°æ¿Ü°ú Á¦Ç°Àº ³ú, ôÃß, ¸»ÃÊ ½Å°æÀ» Æ÷ÇÔÇÑ ¿Ü°ú ¼ö¼ú¿¡ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±¸ ¹× ÀåºñÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°¿¡´Â ¼ö¼ú ±â±¸, ½Å°æ Á¶Àý ÀåÄ¡, ½Å°æ ³»½Ã°æ, µÎ°³°ñ ÀÓÇöõÆ®, ¼ö¼ú ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ µîÀÌ Æ÷ÇԵ˴ϴÙ. ½Å°æ¿Ü°ú Á¦Ç°Àº ³úÁ¾¾ç Á¦°Å, µ¿¸Æ·ù Ä¡·á, ô¼ö ¼ö¼ú, ÆÄŲ½¼º´À̳ª °£Áú°ú °°Àº ½Å°æ Áúȯ¿¡ ´ëÇÑ ³ú½ÉºÎÀڱؿä¹ý(DBS)°ú °°Àº ¼¶¼¼ÇÏ°í º¹ÀâÇÑ ½Ã¼úÀ» ¼öÇàÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½Å°æ¿Ü°ú ¼ö¼úÀº Á¤¹Ðµµ°¡ ¿ä±¸µÇ±â ¶§¹®¿¡ ÀÌ·¯ÇÑ Á¦Ç°µéÀº ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ°í ¼ö¼ú °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ·Îº¿ º¸Á¶ ¼ö¼ú, ÃÖ¼Ò Ä§½À ±â¼ú, ¿Ü°ú Àǻ翡°Ô ³ôÀº Á¤¹Ðµµ¿Í Á¦¾î·ÂÀ» Á¦°øÇϴ ÷´Ü ¿µ»ó ½Ã½ºÅÛ µî ±â¼ú Çõ½ÅÀ¸·Î ½Å°æ¿Ü°ú Á¦Ç°Àº ÇØ¸¶´Ù Å©°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ½Å°æ¿Ü°ú ¼ö¼úÀÇ ÁúÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚÀÇ È¸º¹ ½Ã°£°ú ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙÀÌ´Â µ¥¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½Å°æ¿Ü°ú Á¦Ç° ½ÃÀåÀº ¾î¶»°Ô ¹ßÀüÇϰí Àִ°¡?

½Å°æ¿Ü°ú Á¦Ç° ½ÃÀåÀº ÃÖ¼Òħ½À ¼ö¼úÀÇ È®´ë¿Í ·Îº¿°øÇÐ ¹× ÀΰøÁö´É(AI)°ú °°Àº ÷´Ü ±â¼úÀÇ ÅëÇÕÀ¸·Î ÀÎÇØ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä Æ®·»µå Áß Çϳª´Â ·Îº¿ º¸Á¶ ½Å°æ¿Ü°ú ¼ö¼úÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ¿Ü°úÀÇ»ç´Â ´õ ³ôÀº Á¤¹Ðµµ¿Í Á¦¾î·ÂÀ¸·Î º¹ÀâÇÑ ¼ö¼úÀ» ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ·Îº¿ ½Ã½ºÅÛÀº ¼ÕÀçÁÖ¿Í ½Ã°¢¼ºÀ» Çâ»ó½ÃŰ°í ³ú¿Í ôÃßÀÇ Á¼Àº °ø°£À» ½±°Ô ¿òÁ÷ÀÏ ¼ö ÀÖµµ·Ï ÇÏ¿© ÇÕº´Áõ À§ÇèÀ» ÁÙÀÔ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â ¼ÒÇü Ä«¸Þ¶ó¿Í ±â±¸¸¦ »ç¿ëÇÏ¿© ÃÖ¼Òħ½ÀÀûÀ¸·Î ¼ö¼úÇÏ´Â ½Å°æ³»½Ã°æ ¼ö¼úÀÇ ºÎ»óÀÔ´Ï´Ù. ½Å°æ³»½Ã°æ ¼ö¼úÀº ȯÀÚÀÇ ¿Ü»ó°ú ȸº¹ ½Ã°£À» ÁÙÀÏ ¼ö ÀÖ¾î ³úÁ¾¾ç, ³ú¼öµÎÁõ, ³úÇϼöü Áúȯ µîÀÇ Ä¡·á¿¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ÷´Ü ¼ö¼ú ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀÇ °³¹ß ¶ÇÇÑ ½Å°æ¿Ü°ú ¼ö¼ú¿¡ º¯È­¸¦ °¡Á®¿ÔÀ¸¸ç, ½Ç½Ã°£ 3D ¿µ»ó°ú °¡À̵带 Á¦°øÇÔÀ¸·Î½á ¿Ü°úÀǻ簡 ¼ö¼ú Áß ´õ ¸¹Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¼ö¼ú °èȹ ¹× ¼ö¼ú Áß ÀÇ»ç °áÁ¤¿¡ AI¸¦ ÅëÇÕÇÏ´Â °Íµµ ±â¼ú Çõ½ÅÀÇ ÇÑ ºÐ¾ß·Î, ¼ö¼ú Á¢±Ù¹ýÀ» ÃÖÀûÈ­ÇÏ¿© Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½Å°æ¿Ü°ú Á¦Ç° ¼ö¿ä¸¦ °ßÀÎÇÏ´Â ½Å°æÁúȯÀº?

½Å°æ¿Ü°ú Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ôÀº ÀÌÀ¯´Â ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ ½Å°æÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ³úÁ¾¾ç°ú ¼ö¸·Á¾°ú °°Àº ³úÁ¾¾çÀº ½Å°æ¿Ü°ú Á¦Ç°À¸·Î Ä¡·áÇÏ´Â °¡Àå ÈçÇÑ Áúȯ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼úÀº °Ç°­ÇÑ ³ú Á¶Á÷À» º¸Á¸Çϸ鼭 Á¾¾çÀ» Á¤È®ÇÏ°Ô Á¦°ÅÇϱâ À§ÇØ ¼ö¼ú¿ë Çö¹Ì°æ, ½Å°æ ³»½Ã°æ, µÎ°³°ñ ÀÓÇöõÆ® µîÀÇ µµ±¸¸¦ °áÇÕÇØ¾ß ÇÕ´Ï´Ù. Ãß°£ÆÇ Å»ÃâÁõ, ôÃß°ü ÇùÂøÁõ°ú °°Àº ôÃß ¼Õ»ó ¹× ÅðÇ༺ ôÃß Áúȯµµ ½Å°æ¿Ü°ú Á¦Ç° äÅÃÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½Å°æ¿Ü°ú Á¦Ç°Àº ¶ÇÇÑ ³ú½ÉºÎÀڱؿä¹ý(DBS)°ú °°Àº ½Ã¼ú·Î ÆÄŲ½¼º´, º»Å¼º ¶³¸²°ú °°Àº ¿îµ¿ Àå¾Ö¸¦ Ä¡·áÇÏ´Â µ¥µµ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ƯÁ¤ ³ú ºÎÀ§¿¡ Àü±â ÀÚ±ØÀ» ÁÖ´Â DBS ÀåÄ¡´Â ÀÌ·¯ÇÑ ÁúȯÀÇ Áõ»óÀ» °ü¸®Çϰí ȯÀÚÀÇ »îÀÇ ÁúÀ» °³¼±Çϱâ À§ÇØ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º´º¯ Á¦°Å ¹× ½Å°æ Àڱذú °°Àº ¿Ü°úÀû °³ÀÔÀ» ÅëÇÑ °£Áú Ä¡·áµµ ½Å°æ¿Ü°ú Á¦Ç°ÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ºÐ¾ßÀÔ´Ï´Ù.

½Å°æ¿Ü°ú Á¦Ç° ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº?

½Å°æ¿Ü°ú Á¦Ç° ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ³úÁ¾¾ç, °£Áú, ô¼ö ¼Õ»ó°ú °°Àº ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ¿Ü°ú Àû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä ÃËÁø¿äÀÎÀº ȯÀÚÀÇ ¿Ü»óÀÌ Àû°í ȸº¹ÀÌ ºü¸¥ ÃÖ¼Òħ½ÀÀû ¼ö¼ú ±â¹ýÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ½Å°æ³»½Ã°æ, ·Îº¿ º¸Á¶ ½Ã½ºÅÛ µî ½Å°æ¿Ü°ú Á¦Ç°µéÀº ¿Ü°ú ÀÇ»çµéÀÌ Ä¡·á °á°ú¸¦ °³¼±Çϰí ÇÕº´ÁõÀ» ÁÙÀÌ·Á´Â ³ë·ÂÀ¸·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, AI, ·Îº¿ °øÇÐ, ÷´Ü ¿µ»ó ó¸® ½Ã½ºÅÛÀÇ ÅëÇÕ°ú °°Àº ±â¼ú ¹ßÀüÀº º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ ¼ö¼úÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â ½Å°æ¿Ü°ú Á¦Ç°¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ô¿© ÇØ´ç Áö¿ªÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ½Å°æÇÐ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ º¸Á¶±Ý Áõ°¡¿Í Çõ½ÅÀûÀÎ ¼ö¼ú ±â¼úÀ» ÅëÇÑ È¯ÀÚ ¿¹ÈÄ °³¼±¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½Å°æ¿Ü°ú Á¦Ç° ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 41°³)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Neurosurgical Products Market to Reach US$22.1 Billion by 2030

The global market for Neurosurgical Products estimated at US$11.4 Billion in the year 2023, is expected to reach US$22.1 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2023-2030. Embolization Products, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$8.8 Billion by the end of the analysis period. Growth in the Neurological Endoscopes segment is estimated at 10.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 9.3% CAGR

The Neurosurgical Products market in the U.S. is estimated at US$3.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Neurosurgical Products Market - Key Trends & Drivers Summarized

What Are Neurosurgical Products and Why Are They Vital in Modern Surgery?

Neurosurgical products are specialized medical instruments and devices used in surgical procedures involving the brain, spine, and peripheral nerves. These products include surgical instruments, neuromodulation devices, neuroendoscopes, cranial implants, and surgical navigation systems, among others. Neurosurgical products are vital for performing delicate and complex procedures, such as brain tumor removal, treatment of aneurysms, spinal cord surgeries, and deep brain stimulation (DBS) for neurological conditions like Parkinson’s disease and epilepsy.

The precision required in neurosurgery makes these products indispensable for ensuring patient safety and improving surgical outcomes. Neurosurgical products have evolved significantly over the years, with innovations such as robotic-assisted surgery, minimally invasive techniques, and advanced imaging systems that provide surgeons with greater accuracy and control. These developments are not only enhancing the quality of neurosurgery but are also reducing recovery times and postoperative complications for patients.

How Is the Neurosurgical Products Market Advancing?

The neurosurgical products market is advancing rapidly due to the growing adoption of minimally invasive surgical techniques and the integration of advanced technologies like robotics and artificial intelligence (AI). One of the key trends in this market is the increasing use of robotic-assisted neurosurgery, which allows surgeons to perform complex procedures with greater precision and control. Robotic systems provide enhanced dexterity and visualization, making it easier to navigate tight spaces in the brain and spine, reducing the risk of complications.

Another significant trend is the rise of neuroendoscopic surgery, which uses small cameras and instruments to perform minimally invasive procedures. Neuroendoscopy is becoming a preferred option for treating conditions such as brain tumors, hydrocephalus, and pituitary gland disorders due to its ability to reduce patient trauma and recovery time. The development of advanced surgical navigation systems is also transforming neurosurgery, providing real-time 3D imaging and guidance to help surgeons make more informed decisions during procedures. The integration of AI in surgical planning and intraoperative decision-making is another area of innovation, helping to improve outcomes by optimizing surgical approaches.

Which Neurological Conditions Are Driving Demand for Neurosurgical Products?

Neurosurgical products are in high demand due to the growing prevalence of neurological conditions that require surgical intervention. Brain tumors, including gliomas and meningiomas, are among the most common conditions treated with neurosurgical products. These procedures often require a combination of tools, including surgical microscopes, neuroendoscopes, and cranial implants, to ensure precise tumor removal while preserving healthy brain tissue. Spinal cord injuries and degenerative spine diseases, such as herniated discs and spinal stenosis, are also significant drivers of neurosurgical product adoption.

Neurosurgical products are also widely used in the treatment of movement disorders, such as Parkinson’s disease and essential tremor, through procedures like deep brain stimulation (DBS). DBS devices, which deliver electrical stimulation to specific brain regions, are increasingly being used to manage symptoms of these disorders and improve patients' quality of life. Additionally, the treatment of epilepsy through surgical interventions, including lesion removal and neurostimulation, is another area where neurosurgical products play a critical role.

What Are the Key Growth Drivers in the Neurosurgical Products Market?

The growth in the neurosurgical products market is driven by several factors. One of the primary drivers is the increasing prevalence of neurological disorders, such as brain tumors, epilepsy, and spinal cord injuries, which are creating a higher demand for surgical interventions. Another key driver is the growing adoption of minimally invasive surgical techniques, which are less traumatic for patients and offer faster recovery times. Neurosurgical products that support these techniques, such as neuroendoscopes and robotic-assisted systems, are in high demand as surgeons seek to improve outcomes and reduce complications.

Technological advancements, including the integration of AI, robotics, and advanced imaging systems, are also fueling market growth by enabling more precise and efficient surgeries. Additionally, the increasing investment in healthcare infrastructure, particularly in emerging markets, is expanding access to neurosurgical products and driving growth in these regions. The rise in government funding for neurological research and the growing focus on improving patient outcomes through innovative surgical techniques are further supporting the expansion of the neurosurgical products market.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â